Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine Methylation.

Journal: Cancer Cell

Published: 2019-08-12

DOI: 10.1016/j.ccell.2019.07.003

Affiliations: 22

Authors: 35

Go to article
Institutions Share
Institute of Molecular and Cell Biology (IMCB), A*STAR, Singapore 0.22
Structural Genomics Consortium (SGC Toronto), Canada 0.10
Human Oncology and Pathogenesis Program (HOPP), MSKCC, United States of America (USA) 0.10
IRCCS IDE Department of Experimental Oncology, Italy 0.09
GlaxoSmithKline R&D Collegeville, United States of America (USA) 0.09
Department of Oncological Sciences, ISMMS, United States of America (USA) 0.08
Tisch Cancer Institute (TCI), ISMMS, United States of America (USA) 0.08
Ontario Cancer Institute (OCI), U of T, Canada 0.04
Department of Hematology, Erasmus MC, Netherlands 0.04
NUS Department of Biochemistry (BCH), Singapore 0.03
Joan and Sanford I. Weill Department of Medicine, Cornell University, United States of America (USA) 0.03
Department of Pharmacology, Cornell University, United States of America (USA) 0.03
Center for Therapeutics Discovery, ISMMS, United States of America (USA) 0.02
Department of Pharmacological Sciences, ISMMS, United States of America (USA) 0.02
Division of Hematology and Medical Oncology, Cornell University, United States of America (USA) 0.01
NUS Graduate School for Integrative Sciences and Engineering (NGS), Singapore 0.01
Department of Medicine, MSKCC, United States of America (USA) 0.01
Leukemia Service, MSKCC, United States of America (USA) 0.01

Return